Critical illness myopathy and neuropathy

Current Opinion in Critical Care

Volumn 11, Issue 2, 2005, Pages 126-132

  Latronico, Nicola ^a   Peli, Elena ^a   Botteri, Marco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Mitochondrial dysfunction; Multi organ failure; Myopathy; Neuropathy; Polyneuropathy; Sepsis

Indexed keywords

ADENOSINE TRIPHOSPHATE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); STEROID;

ACTIN MYOSIN INTERACTION; APOPTOSIS; BIOENERGY; CLINICAL FEATURE; CRITICAL ILLNESS; CRITICAL ILLNESS MYOPATHY; CRITICAL ILLNESS NEUROPATHY; DEPLETION; DIAGNOSTIC TEST; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG UTILIZATION; DYSLIPIDEMIA; ELECTROPHORESIS; ELECTROPHYSIOLOGY; HIGH RISK POPULATION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; METABOLIC DISORDER; MICROVASCULATURE; MULTIPLE ORGAN FAILURE; MUSCLE EXCITATION; MUSCLE LEVEL; MYOFILAMENT; MYOPATHY; NEUROPATHY; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RESPIRATORY CHAIN; REVIEW; RISK FACTOR; SEPSIS;

CRITICAL ILLNESS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MUSCULAR DISEASES; POLYNEUROPATHIES; RISK FACTORS;

EID: 16844364900     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccx.0000155357.24360.89     Document Type: Review

References (62)

1. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984; 47:1223-1231.
2. Zochodne DW, Bolton CF, Wells GA, et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987; 110:819-841.
3. Helliwell TR, Coakley JH, Wagenmakers AJ, et al. Necrotizing myopathy in critically-ill patients. J Pathol 1991; 164:307-314.
4. Op de Coul AA, Verheul GA, Leyten AC, et al. Critical illness polyneuromyopathy after artificial respiration. Clin Neurol Neurosurg 1991; 93:27-33.
5. Coakley JH, Nagendran K, Honavar M, Hinds CJ. Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med 1993; 19:323-328.
6. De Smet Y. Status asthmaticus. Acute myopathy induced by cortisone and neuropathy during resuscitation. Rev Neurol (Paris) 1993; 149:573-576.
7. Ramsay DA, Zochodne DW, Robertson DM, et al. A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropathol Exp Neurol 1993; 52:387-398.
8. Verheul GA, de Jongh-Leuvenink J, Op de Coul AA, et al. Tumor necrosis factor and interleukin-6 in critical illness polyneuromyopathy. Clin Neurol Neurosurg 1994; 96:300-304.
9. Zochodne DW, Ramsay DA, Saly V, et al. Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994; 17:285-292.
10. Helliwell TR, Wilkinson A, Griffiths RD, et al. Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin. Neuropathol Appl Neurobiol 1998; 24:507-517.
11. Bazzi P, Moggio M, Prelle A, et al. Critically ill patients: immunological evidence of inflammation in muscle biopsy. Clin Neuropathol 1999; 18:23-30.
12. De Letter MA, van Doorn PA, Savelkoul HF, et al. Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol 2000; 106: 206-213.
13. Trojaborg W, Weimer LH, Hays AP. Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy-a reappraisal. Clin Neurophysiol 2001; 112:1586-1593.
14. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360:219-223.
15. Bednarik J, Lukas Z, Vondracek P. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med 2003; 29:1505-1514. In this prospective study patients were investigated with a complex array of clinical, electrophysiological, and histological investigations. Direct muscle stimulation was technically demanding, and concordance with muscle biopsy data was limited.
16. Latronico N, Fenzi F, Recupero D, et al. Critical illness myopathy and neuropathy. Lancet 1996; 347:1579-1582.
17. Rich MM, Teener JW, Raps EC, et al. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996; 46:731-736.
18. Rich MM, Bird SJ, Raps EC, et al. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997; 20:665-673.
19. Latronico N. Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both? Intensive Care Med 2003; 29:1411-1413.
20. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996; 24:1408-1416.
21. Morisaki H, Sibbald WJ. Tissue oxygen delivery and the microcirculation. Crit Care Clin 2004; 20:213-223.
22. Fenzi F, Latronico N, Refatti N, Rizzuto N. Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol (Berl) 2003; 106:75-82. This is the first demonstration that E-selectin, an adhesion molecule, is expressed in the endothelium of the epineurial and endoneurial vessels of peripheral nerves of critically ill septic patients with CIP.
23. Druschky A, Herkert M, Radespiel-Troger M, et al. Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med 2001; 27:686-693.
24. Fink MP, Evans TW. Mechanisms of organ dysfunction in critical illness: report from a Round Table Conference held in Brussels. Intensive Care Med 2002; 28:369-375.
25. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
26. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27:1230-1251.
27. Sharshar T, Chevret S, Bourdain F, Raphael JC. Early predictors of mechanical ventilation in Guillain-Barre syndrome. Crit Care Med 2003; 31: 278-283.
28. Van der Meche FG, Van Doom PA, Meulstee J, Jennekens FG. Diagnostic and classification criteria for the Guillain-Barre syndrome. Eur Neurol 2001; 45:133-139.
29. Leijten FS, Harinck-de Weerd JE, Poortvliet DC, de Weerd AW. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995; 274:1221-1225.
30. de Letter MA, Visser LH, van der Meche FG, et al. Distinctions between critical illness polyneuropathy and axonal Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2000; 68:397-398.
31. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group: Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Lancet 1997; 349:225-230.
32. van Koningsveld R, Schmitz PI, Meche FG, et al. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomised trial. Lancet 2004; 363:192-196.
33. De Jonghe B, Cook D, Sharshar T, et al. Acquired neuromuscular disorders in critically ill patients: a systematic review. Groupe de Reflexion et d'Etude sur les Neuromyopathies En Reanimation. Intensive Care Med 1998; 24:1242-1250.
34. Berek K, Margreiter J, Willeit J, et al. Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 1996; 22:849-855.
35. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001; 27:1288-1296.
36. Tepper M, Rakic S, Haas JA, Woittiez AJ. Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth J Med 2000; 56:211-214.
37. Witt NJ, Zochodne DW, Bolton CF, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991; 99:176-184.
38. De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002; 288:2859-2867.
39. Leijten F. Neuromuscular complications of prolonged critical care. In: Yearbook of Intensive Care and Emergency Medicine, edition. Edited by Vincent JL (Editor). Berlin: Springer-Verlag; 1997. pp. 774-786.
40. Latronico N, Candiani A. Muscular wasting as a consequence of sepsis. In: Anaesthesia, Pain, Intensive Care and Emergency Medicine, A.P.I.C.E. 13th. edition. Edited by Gullo A (Editor). Milan: Springer-Verlag; 1998. pp. 517-522.
41. Lacomis D, Zochodne DW, Bird SJ. Critical illness myopathy. Muscle Nerve 2000; 23:1785-1788.
42. Rich MM, Pinter MJ, Kraner SD, Barchi RL. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 1998; 43:171-179.
43. Rich MM, Pinter MJ. Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol 2001; 50:26-33.
44. Rich MM, Pinter MJ. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol 2003; 547:555-566. In an experimental model of denervated rat muscle fibers and high-dose steroid, the authors demonstrate that a shift in the voltage dependence of sodium channel fast inactivation to more negative potentials has a crucial role to cause muscle inexcitability.
45. Filatov GN, Rich MM. Hyperpolarized shifts in the voltage dependence of fast inactivation of Nav1.4 and Nav1.5 in a rat model of critical illness myopathy. J Physiol 2004; 559:813-820. In an experimental model of denervated rat muscle fibers and high-dose steroid, the authors demonstrate an increased density of embryonic sodium channel isoforms. Increased density did not correlate with muscle unexcitability, which was explained by the hyperpolarized shift in both embryonic and adult sodium channel isoforms.
46. Latronico N, Rasulo FA, Recupero D, et al. Acute quadriplegia with delayed onset and rapid recovery. Case report. J Neurosurg 1998; 88:769-772.
47. Lycklama A, Nijeholt J, Troost J. Critical illness polyneuropathy. In: Handbook of Clinical Neurology. Revised Series 7. edition. Edited by Vinken P, Bruyn G, Klawans H (Editors). Amsterdam: Elsevier/North Holland; 1987. pp. 575-585.
48. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 1996; 335:1897-1905.
49. Showalter CJ, Engel AG. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997; 20:316-322.
50. Tiao G, Hobler S, Wang JJ, et al. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest 1997; 99:163-168.
51. Sher JH, Shafiq SA, Schutta HS. Acute myopathy with selective lysis of myosin filaments. Neurology 1979; 29:100-106.
52. Di Giovanni S, Molon A, Broccolini A, et al. Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 2004; 55:195-206. Activation of the TGF-beta/MAPK pathway is specific of critical illness myopathy. It is not seen in neurogenic atrophy, or in inflammatory myopathies.
53. Coakley JH, Nagendran K, Yarwood GD, et al. Patterns of neurophysiological abnormality in prolonged critical illness. Intensive Care Med 1998; 24:801-807.
54. Latronico N, Guarneri B, Bera P, et al. La critical illness myopathy and neuropathy. In: Approfondimenti in Terapia Intensiva. edition. Edited by Brazzi L (Editor). Milan: Time Science; 2000. pp. 59-85.
55. Stibler H, Edstrom L, Ahlbeck K, et al. Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med 2003; 29:1515-1527. A net reduction of the myosin/actin ratio seems specific of critical illness myopathy, and can be rapidly (24 hours) diagnosed using an electrophoretic method.
56. Campellone JV, Lacomis D, Kramer DJ, et al. Acute myopathy after liver transplantation. Neurology 1998; 50:46-53.
57. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710.
58. Ferreira FL, Bota DP, Brass A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286:1754-1758.
59. Mesotten D, Swinnen JV, Vanderhoydonc F, et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 2004; 89:219-226. Normalization of the serum lipid profile rather than glucose control independently determines the beneficial effects of intensive insulin therapy on mortality and morbidity, including critical illness polyneuropathy.
60. Fletcher SN, Kennedy DD, Ghosh IR, et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003; 31:1012-1016.
61. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348:683-693.
62. Leijten FS. Survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348:2149-2150; author reply 2149-2150.